P188: One year survival of treated non-small cell lung carcinoma in elderly in Cipto Mangunkusumo Hospital and Dharmais Cancer Hospital

Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and one year survival of lung cancer in Sanglah hospital

“…This is shorter than the study at RSCM and Dharmais Hospital Jakarta which showed 34.8% survival at 1 year but the study covered all stages and not only advanced stages as in this study. 15 In this study, the median survival was 1.15 months in the group that did not receive therapy, not much different from study in Jakarta which showed a median survival of 2 months. 3 In this study, the hazard ratio (HR) of NLR>3.37 was 2.75 (95% CI 1.52-4.98) and was statistically significant.…”

“…12 Histological diagnosis lung adenocarcinoma was the most common diagnosis in this study, other studies have also shown that the most common type of histology is adenocarcinoma. 3,[12][13][14][15] The initial performance status of patients in this study, 31.3% was ECOG>2, which indicates that patients should receive general improvement management before receiving therapy for their cancer. This is different from the research in Jakarta which showed that performance status of most sample was ECOG 2, and there was no sample with ECOG>2, with most of the patient education being high school, while in this study the level of education mostly elementary school.…”